We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
- Authors
Boltze, Johannes; Abe, Koji; Clarkson, Andrew N.; Detante, Oliver; Pimentel-Coelho, Pedro M.; Rosado-de-Castro, Paulo H.; Janowski, Miroslaw
- Abstract
Keywords: stem cells; stroke; mesenchymal stem cells (MSC); brain; treatment; translational medicine; ischemia; clinical trials EN stem cells stroke mesenchymal stem cells (MSC) brain treatment translational medicine ischemia clinical trials 1 3 3 04/07/20 20200403 NES 200403 The introduction of recanalization procedures has revolutionized acute stroke management, although factors such as the narrow time window, strict eligibility criteria, and logistical limitations still exclude the majority of patients from treatment. However, efficacy results initially reported in clinical studies fell short of expectations ([5]) raising concerns that cell treatment might eventually share the "dead end fate" of many previous experimental stroke therapies. Stem cells, stroke, mesenchymal stem cells (MSC), brain, treatment, translational medicine, ischemia, clinical trials.
- Subjects
STROKE; MESENCHYMAL stem cells; NEURAL stem cells
- Publication
Frontiers in Neurology, 2020, p1
- ISSN
1664-2295
- Publication type
Editorial
- DOI
10.3389/fneur.2020.00171